Graduate Program in Biomedical Engineering, Price Faculty of Engineering, University of Manitoba, Winnipeg, Canada.
Neuroscience Research Program, Kleysen Institute for Advanced Medicine, Health Sciences Centre, Winnipeg, Canada.
Brain Connect. 2023 Aug;13(6):356-366. doi: 10.1089/brain.2020.0937. Epub 2021 Aug 23.
Regional hypermetabolism in Alzheimer's disease (AD), especially in the cerebellum, has been consistently observed but often neglected as an artefact produced by the commonly used proportional scaling procedure in the statistical parametric mapping. We hypothesize that the hypermetabolic regions are also important in disease pathology in AD. Using fluorodeoxyglucose (FDG)-positron emission tomography (PET) images from 88 AD subjects and 88 age-sex matched normal controls (NL) from the publicly available Alzheimer's Disease Neuroimaging Initiative database, we developed a general linear model-based classifier that differentiated AD patients from normal individuals (sensitivity = 87.50%, specificity = 82.95%). We constructed region-region group-wise correlation matrices and evaluated differences in network organization by using the graph theory analysis between AD and control subjects. We confirmed that hypermetabolism found in AD is not an artefact by replicating it using white matter as the reference region. The role of the hypermetabolic regions has been further investigated by using the graph theory. The differences in betweenness centrality (BC) between AD and NL network were correlated with region weights of FDG PET-based AD classifier. In particular, the hypermetabolism in cerebellum was accompanied with higher BC. The brain regions with higher BC in AD network showed a progressive increase in FDG uptake over 2 years in prodromal AD patients ( = 39). This study suggests that hypermetabolism found in AD may play an important role in forming the AD-related metabolic network. In particular, hypermetabolic cerebellar regions represent a good candidate for further investigation in altered network organization in AD.
阿尔茨海默病(AD)患者的区域性代谢亢进,特别是小脑代谢亢进,已被持续观察到,但通常被认为是统计参数映射中常用的比例缩放过程产生的伪影而被忽视。我们假设代谢亢进区域在 AD 的疾病病理中也很重要。
我们使用来自公开的阿尔茨海默病神经影像学倡议数据库的 88 名 AD 患者和 88 名年龄性别匹配的正常对照者(NL)的氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)图像,开发了一种基于广义线性模型的分类器,可将 AD 患者与正常个体区分开(敏感性=87.50%,特异性=82.95%)。我们构建了区域-区域组间相关性矩阵,并通过使用图论分析评估 AD 和对照受试者之间的网络组织差异。我们通过将白质作为参考区域来复制代谢亢进,从而证实了 AD 中发现的代谢亢进不是伪影。通过图论进一步研究了代谢亢进区域的作用。AD 和 NL 网络之间的节点介数(BC)差异与基于 FDG PET 的 AD 分类器的区域权重相关。特别是,小脑的代谢亢进与更高的 BC 相关。AD 网络中 BC 较高的脑区在 AD 患者(n=39)的前体期 2 年内 FDG 摄取呈逐渐增加趋势。
这项研究表明,AD 中发现的代谢亢进可能在形成 AD 相关代谢网络中发挥重要作用。特别是,代谢亢进的小脑区域可能是 AD 网络组织改变的候选研究对象。